Evommune Inc (EVMN)
NYSE
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Dr. David Eric CohenIndependent Director | -6.06k | 123.09k | Automatic Disposition | 20.21 - 21.38 | 17.61k | -25.59% |
| 2026-06-01 | Dr. Jeegar PatelChief Scientific Officer | -13.51k | 255.38k | Derivative Exercise and Sale | 3.84 - 22.74 | 5.97k | - |
| 2026-06-01 | Dr. Jeegar PatelChief Scientific Officer | -3.18k | 72.20k | Automatic Disposition | 22.74 | 5.97k | -34.73% |
| 2026-06-01 | Mr. Luis C. PenaFounder, President, CEO & Director | -16.79k | 381.74k | Automatic Disposition | 22.74 | 496.14k | -3.27% |
| 2026-05-28 | Mr. Gregory S. MossChief Business & Legal Officer, Corporate Secretary and CCO | -14.22k | 300.39k | Derivative Exercise and Sale | 1.71 - 22.83 | 8.17k | - |
| 2026-05-28 | Mr. Kyle CarverCFO | -15.00k | 297.75k | Derivative Exercise and Sale | 2.99 - 22.84 | 4.87k | - |
| 2026-05-28 | Mr. Kyle CarverCFO | -3.18k | 72.52k | Automatic Disposition | 22.84 | 4.87k | -39.49% |
| 2025-12-19 | Dr. Robert L. HopfnerIndependent Director | 1,000.00 | 17.35k | 買い | 17.35 | 4.03k | 33.05% |
| 2025-12-09 | Dr. Jeegar PatelChief Scientific Officer | -7.51k | 134.03k | Sale to Issuer | 17.84 | 9.14k | -45.11% |
| 2025-12-09 | Mr. Luis C. PenaFounder, President, CEO & Director | -28.14k | 501.98k | Sale to Issuer | 17.84 | 512.93k | -5.20% |
| 2025-12-09 | Mr. Gregory S. MossChief Business & Legal Officer, Corporate Secretary and CCO | -13.62k | 243.05k | Sale to Issuer | 17.84 | 8.17k | -62.52% |
| 2025-12-09 | Mr. Kyle CarverCFO | -13.29k | 237.09k | Sale to Issuer | 17.84 | 8.04k | -62.30% |
| 2025-12-09 | Ms. Janice DrewChief of Development Operations | -5.07k | 90.52k | Sale to Issuer | 17.84 | 40.75k | -11.07% |
| 2025-12-09 | Dr. Eugene Andrew BauerCo-Founder, Chief Medical Officer & Director | -1.48k | 26.37k | Sale to Issuer | 17.84 | 262.05k | -0.56% |
| 2025-11-07 | RA Capital Management, L.P.法人 | 2.21M | 0.00 | Derivative Exercise and Retained Stock | - | 3.46M | 176.70% |
| 2025-11-07 | RA Capital Management, L.P.法人 | 1.25M | 20.00M | 買い | 16.00 | 3.46M | 56.59% |
| 2025-11-07 | Eqt Fund Management S.à R.L.法人 | 3.37M | 0.00 | Derivative Exercise and Retained Stock | - | 4.93M | 215.50% |
| 2025-11-07 | Eqt Fund Management S.à R.L.法人 | 1.56M | 25.00M | 買い | 16.00 | 4.93M | 46.40% |
| 2025-11-07 | Mr. Luis C. PenaFounder, President, CEO & Director | 24.23k | 0.00 | Derivative Exercise and Retained Stock | - | 493.82k | 5.16% |
| 2025-11-07 | Dr. Jeegar PatelChief Scientific Officer | 3.18k | 0.00 | Derivative Exercise and Retained Stock | - | 3.18k | - |
| 2025-11-07 | Mr. Gregory S. MossChief Business & Legal Officer, Corporate Secretary and CCO | 3.18k | 0.00 | Derivative Exercise and Retained Stock | - | 3.18k | - |
| 2025-11-07 | Dr. Robert L. HopfnerIndependent Director | 3.03k | 0.00 | Derivative Exercise and Retained Stock | - | 3.03k | - |
| 2025-11-07 | Pivotal BioVenture Partners LLC法人 | 1.93M | 0.00 | Derivative Exercise and Retained Stock | - | 1.93M | - |
| 2025-11-07 | NFLS Delta III Limited法人 | 1.44M | 0.00 | Derivative Exercise and Retained Stock | - | 1.44M | - |
| 2025-11-07 | Ms. Janice DrewChief of Development Operations | 1.59k | 0.00 | Derivative Exercise and Retained Stock | - | 36.81k | 4.51% |
| 2025-11-07 | Dr. David Eric CohenIndependent Director | 6.06k | 0.00 | Derivative Exercise and Retained Stock | - | 23.67k | 34.39% |
| 2025-11-07 | Mr. Kyle CarverCFO | 3.18k | 0.00 | Derivative Exercise and Retained Stock | - | 3.18k | - |
| 2025-11-07 | Dr. Eugene Andrew BauerCo-Founder, Chief Medical Officer & Director | 25.81k | 0.00 | Derivative Exercise and Retained Stock | - | 260.61k | 10.99% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。